Amgen news from FierceBioResearcher
NewsThe race is on for muscle-enhancing therapies
The key to extraordinary muscle growth is inhibiting the gene that expresses myostatin, which blocks the growth of skeletal muscle. And now there's a race among a group of drug developers to bring a Read more...
| Press ReleasesFDA Receives New Data on Risks of Anemia Drugs FDA Receives New Data on Risks of Anemia Drugs Consistent With Previous Data on Tumor Growth and Death The U.S. Food and Drug Administration (FDA) is reviewing new data from two studies that provide Read more... PRESS RELEASE: Amgen Pivotal Phase 3 Data Show Denosumab Increased Bone Density Throughout Skeleton in Non-Metastatic Breast Can Amgen Pivotal Phase 3 Data Show Denosumab Increased Bone Density Throughout Skeleton in Non-Metastatic Breast Cancer Patients on Adjuvant Aromatase Inhibitor Therapy SAN ANTONIO -- Amgen today Read more... PRESS RELEASE: Pivotal Phase 3 Romiplostim Study in Splenectomized Patients Meets Primary Endpoints Pivotal Phase 3 Romiplostim Study in Splenectomized Patients Meets Primary Endpoints Data Show Romiplostim Increased and Sustained Platelet Counts in Splenectomized Adult Patients with Immune Read more... PRESS RELEASE: Amgen Announces Interim Results of Aranesp ''PREPARE'' Study in Breast Cancer Patients Amgen Announces Interim Results of Aranesp ''PREPARE'' Study in Breast Cancer Patients THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Amgen, Inc. (NASDAQ: AMGN - News) today announced that it had received Read more... PRESS RELEASE: FDA approves Mircera: first renal anemia treatment in the US with monthly maintenance dosing FDA approves Mircera: first renal anemia treatment in the US with monthly maintenance dosing Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Mircera (methoxy Read more... |
Get more Amgen coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets